16.05.2024 12:49:33 - dpa-AFX: *ARVINAS, PFIZER ANNOUNCE UPDATED CLINICAL DATA FROM PHASE 1B TRIAL OF VEPDEGESTRANT WITH PALBOCICLIB

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
PFIZER INC. DL-,05 852009 Frankfurt 27,210 06.06.24 08:29:31 +0,210 +0,78% 27,110 27,210 27,210 27,000

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH